Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 7, 2007

Agilent to Boost Automated Sample-Prep Offerings with Velocity11 Takeover

  • Agilent Technologies says that it plans to acquire Velocity11 to strengthen its automated sample-preparation solutions.
    Velocity11 makes automated liquid-handling products and laboratory robotics for the life science market. The company designs, manufactures, and markets products that range from standalone instrumentation to benchtop automation solutions to large, multiarmed robotic systems. Velocity11 also develops software to control the robotics.

    “Velocity11 is a market leader in lab automation with a solid reputation for innovative technology, quality products, and superb customer service,” comments Nick Roelofs, vp of Agilent’s life science systems and solutions unit. “Together, we can offer customers a comprehensive set of workflow solutions with increased levels of automation, which can help speed drug discovery and genetic research.”



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »